Online citations, reference lists, and bibliographies.
← Back to Search

Galactosyl Derivatives Of L-arginine And D-arginine: Synthesis, Stability, Cell Permeation, And Nitric Oxide Production In Pituitary GH3 Cells.

D. Melisi, A. Secondo, P. Montoro, S. Piacente, M. G. Rimoli, M. Minale, P. de Caprariis, L. Annunziato
Published 2006 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Nitric oxide (NO) is critical for the normal physiological regulation of the nervous system and other tissues. L-Arginine, but not D-arginine, is the natural substrate for nitric oxide synthase (NOS), for it is enzymatically converted to NO and L-citrulline. However, recent evidence suggests that D-arginine can also produce NO and NO-derivatives via a different pathway. The aim of the present paper was to raise NO levels in the cells by increasing the cell permeation of its precursors. To this aim, two galactosyl prodrugs, L-arginine-D-galactos-6'-yl ester (L-ArgGal) and D-arginine-D-galactos-6'-yl ester (D-ArgGal) were synthesized. Remarkably, using the HPLC-ESI/MS technique, we found that L-ArgGal and D-ArgGal prodrugs both increased the concentration levels of L- and D-arginine and their derivatives in pituitary GH3 cells. Furthermore, we found that D-ArgGal (1) penetrated cell membranes more rapidly than its precursor D-arginine, (2) released arginine more slowly and in greater amounts than L-ArgGal, and (3) produced much higher levels of DAF-2 monitored NO and nitrite than did L-ArgGal under the same experimental conditions. In conclusion, these results indicate that an increase in the cell permeation of L- and D-arginine by L-ArgGal and D-ArgGal can lead to an increase in NO levels.



This paper is referenced by
10.1124/mol.110.069658
Nitric Oxide Stimulates NCX1 and NCX2 but Inhibits NCX3 Isoform by Three Distinct Molecular Determinants
A. Secondo (2011)
10.1021/acs.molpharmaceut.7b00626
Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis.
Francesca Di Guida (2018)
10.1039/c0ob01117g
Prodrug design for the potent cardiovascular agent Nω-hydroxy-L-arginine (NOHA): synthetic approaches and physicochemical characterization.
D. Schade (2011)
10.1002/jcp.21876
Galactosyl derivative of Nω‐nitro‐L‐arginine: Study of antiproliferative activity on human thyroid follicular carcinoma cells
D. Melisi (2009)
10.1016/j.neubiorev.2011.02.009
d-Arginine action against neurotoxicity induced by glucocorticoids in the brain
Canteros Maria Griselda (2011)
Photodynamic therapy in nanomedicine: synthesis and multidisciplinary characterization of squaraine sensitizers for theranostics
E. Ronchi (2012)
Heteromeres d'arginine pour administration locale
J. Waugh (2006)
10.1016/j.drudis.2013.11.010
D-Arginine as a neuroprotective amino acid: promising outcomes for neurological diseases.
M. Canteros (2014)
10.1021/jm900051r
Galactosyl prodrug of ketorolac: synthesis, stability, and pharmacological and pharmacokinetic evaluations.
A. Curcio (2009)
10.1016/j.ejphar.2011.01.045
The galactosylation of N(ω)-nitro-L-arginine enhances its anti-nocifensive or anti-allodynic effects by targeting glia in healthy and neuropathic mice.
C. Giordano (2011)
10.1021/acs.jmedchem.6b00810
Design, Synthesis, and Bioactivation of O-Glycosylated Prodrugs of the Natural Nitric Oxide Precursor N(ω)-Hydroxy-l-arginine.
Felix-A Litty (2016)
10.1002/cmdc.201700762
Application of Mono‐ and Disaccharides in Drug Targeting and Efficacy
S. Yu-an (2018)
10.1016/j.ejps.2014.05.009
Galactosyl prodrug of palmitoylethanolamide: synthesis, stability, cell permeation and cytoprotective activity.
Elvira Luongo (2014)
10.1292/jvms.19-0630
Orally administrated D-arginine exhibits higher enrichment in the brain and milk than L-arginine in ICR mice
K. Aso (2020)
Semantic Scholar Logo Some data provided by SemanticScholar